Invesco Ltd. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$30,042,894
-8.6%
294,943
-9.5%
0.01%
-11.1%
Q2 2023$32,870,524
-10.2%
325,741
-18.1%
0.01%
-10.0%
Q1 2023$36,606,156
+20.5%
397,893
+18.8%
0.01%
+11.1%
Q4 2022$30,375,233
+9.5%
334,824
-8.2%
0.01%0.0%
Q3 2022$27,731,000
-1.1%
364,837
+10.0%
0.01%
+12.5%
Q2 2022$28,035,000
-2.5%
331,658
+1.2%
0.01%
+14.3%
Q1 2022$28,753,000
+12.8%
327,674
+12.4%
0.01%
+16.7%
Q4 2021$25,496,000
-17.3%
291,490
-22.7%
0.01%
-25.0%
Q3 2021$30,838,000
-34.2%
377,081
-26.6%
0.01%
-33.3%
Q2 2021$46,887,000
-26.2%
513,880
-30.9%
0.01%
-29.4%
Q1 2021$63,527,000
-31.1%
743,178
-23.9%
0.02%
-37.0%
Q4 2020$92,192,000
-32.3%
976,302
-37.7%
0.03%
-41.3%
Q3 2020$136,216,000
-2.5%
1,566,413
-2.1%
0.05%
-8.0%
Q2 2020$139,760,000
-13.0%
1,600,179
-17.8%
0.05%
-26.5%
Q1 2020$160,579,000
-14.6%
1,947,597
-2.0%
0.07%
+17.2%
Q4 2019$188,102,000
+5.8%
1,986,505
-2.9%
0.06%
+23.4%
Q3 2019$177,873,000
-12.5%
2,046,871
-8.0%
0.05%
-9.6%
Q2 2019$203,224,000
+20.7%
2,225,649
+27.1%
0.05%
-8.8%
Q1 2019$168,380,000
+3.5%
1,751,408
-7.7%
0.06%
-8.1%
Q4 2018$162,762,000
-16.0%
1,896,785
-15.7%
0.06%
+1.6%
Q3 2018$193,768,000
+5.0%
2,248,929
-7.9%
0.06%0.0%
Q2 2018$184,469,000
+3.2%
2,441,997
+10.5%
0.06%
-9.0%
Q1 2018$178,749,000
+0.6%
2,210,868
+4.5%
0.07%
+4.7%
Q4 2017$177,622,000
+4.9%
2,115,549
+7.3%
0.06%
+1.6%
Q3 2017$169,298,000
+13.3%
1,972,033
+10.1%
0.06%
+34.0%
Q2 2017$149,462,000
+4.4%
1,790,606
-7.1%
0.05%0.0%
Q1 2017$143,220,000
+1.3%
1,928,372
-0.7%
0.05%
-2.1%
Q4 2016$141,386,000
-12.7%
1,941,041
-5.4%
0.05%
-14.3%
Q3 2016$162,025,000
-6.2%
2,051,992
-2.0%
0.06%
-11.1%
Q2 2016$172,799,000
+5.5%
2,094,259
-7.4%
0.06%
-6.0%
Q1 2016$163,786,000
-15.9%
2,260,988
-0.1%
0.07%
-14.1%
Q4 2015$194,795,000
-3.6%
2,264,007
+3.0%
0.08%
-9.3%
Q3 2015$202,005,000
-17.8%
2,197,619
-12.0%
0.09%
-10.4%
Q2 2015$245,677,000
-12.9%
2,498,230
-12.6%
0.10%
-11.9%
Q1 2015$281,932,000
-0.4%
2,859,075
-6.4%
0.11%0.0%
Q4 2014$283,063,000
+2.0%
3,054,868
+3.7%
0.11%
-1.8%
Q3 2014$277,423,000
+9.4%
2,947,238
+5.2%
0.11%
+11.0%
Q2 2014$253,567,000
-24.6%
2,800,911
-29.2%
0.10%
-26.5%
Q1 2014$336,306,000
+11.2%
3,955,607
+5.1%
0.14%
+13.3%
Q4 2013$302,470,000
+5.0%
3,762,992
+0.2%
0.12%
-4.0%
Q3 2013$288,051,000
-7.0%
3,755,075
-14.3%
0.12%
-13.2%
Q2 2013$309,818,0004,381,5270.14%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders